Recent Finacing
Recent Raise
Alethia Biotherapeutics is a Montreal-based biotechnology company that develops monoclonal antibodies using its STAR discovery platform to identify tissue-specific targets, advancing programs against Siglec-15, clusterin, and KAAG-1.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
